Latest News on GL

Financial News Based On Company


Advertisement
Advertisement

TD Cowen maintains Globe Life at Buy, raises price target to $218 from $215

https://www.tradingview.com/news/tradingview:8ec4e5882c4d1:0-td-cowen-maintains-globe-life-at-buy-raises-price-target-to-218-from-215/
TD Cowen has reiterated its 'Buy' rating for Globe Life and increased its price target from $215 to $218, representing a 1.4% rise. This new price target suggests a potential upside of 35.6% from the stock's closing price on November 13th. Other analysts have recently set price targets for Globe Life ranging from $165 to $215.

GL Stock Gains 22.3% in a Year: Here's What Investors Should Know

https://www.tradingview.com/news/zacks:8dc557977094b:0-gl-stock-gains-22-3-in-a-year-here-s-what-investors-should-know/
Globe Life Inc. (GL) shares have increased by 22.3% over the past year due to strong operating performance, premium growth, higher investment income, and disciplined capital allocation. The company is considered affordable compared to its industry, with optimistic growth projections and a high return on equity. Despite potential risks from inflation and distribution challenges, GL's overall prospects are positive, supported by technology investments and strategic expansions.

Form 144 Globe Life Inc For: 14 November By Investing.com

https://ng.investing.com/news/stock-market-news/form-144-globe-life-inc-for-14-november-93CH-2808193
This article announces the filing of Form 144 for Globe Life Inc., specifically for transactions that occurred on November 14th. The filing is a standard disclosure related to the sale of restricted securities. The brief article, published by Investing.com, provides no further details beyond the announcement itself.

Form 4 Globe Life Inc: Rebecca E. Zorn (EVP & Chief Talent Officer) For: 11 November

https://za.investing.com/news/stock-market-news/form-4-globe-life-inc-rebecca-e-zorn-evp--chief-talent-officer-for-11-november-93CH-4574892
This article reports on a Form 4 filing for Globe Life Inc., detailing an insider transaction involving Rebecca E. Zorn, the EVP & Chief Talent Officer. The transaction date is specified as November 11. The article itself was published on November 13, 2026, at 19:50.

Globe Life EVP & chief talent officer sells $161,530 in stock

https://ca.investing.com/news/stock-market-news/globe-life-evp--chief-talent-officer-sells-161530-in-stock-93CH-4957615
Rebecca E. Zorn, EVP and Chief Talent Officer at Globe Life Inc. (NYSE:GL), sold 1,000 shares of company stock for $161,530 and simultaneously acquired 1,000 shares through employee stock options for $98,320 on November 11, 2026. Following these transactions, she holds over 17,600 shares directly and 13,200 employee stock options. The article also touches on recent financial results, analyst ratings, and company bylaws.
Advertisement

Globe Life EVP & chief talent officer sells $161,530 in stock

https://in.investing.com/news/stock-market-news/globe-life-evp--chief-talent-officer-sells-161530-in-stock-93CH-5703818
Rebecca E. Zorn, Executive Vice President and Chief Talent Officer at Globe Life Inc., sold 1,000 shares of company stock for approximately $161,530 on November 11, 2026. On the same day, Ms. Zorn acquired 1,000 shares through employee stock options for $98,320 and gifted 166 shares. These transactions follow Globe Life's recent Q3 2026 financial results, which saw varied analyst responses due to mixed earnings and revenue, alongside strategic adjustments to company bylaws.

Form 4 Globe Life Inc: Rebecca E. Zorn (EVP & Chief Talent Officer) For: 11 November

https://uk.investing.com/news/stock-market-news/form-4-globe-life-inc-rebecca-e-zorn-evp--chief-talent-officer-for-11-november-93CH-4981728
This article reports on a Form 4 filing for Globe Life Inc., specifically detailing activity for Rebecca E. Zorn, the EVP & Chief Talent Officer, related to November 11. It's a brief announcement of an insider transaction.

After exercising 1,000 options, Globe Life (GL) executive Zorn sold 1,000 shares and gave 166.

https://www.stocktitan.net/sec-filings/GL/form-4-globe-life-inc-insider-trading-activity-b8840a5941f0.html
Globe Life Inc. (GL) EVP & Chief Talent Officer Rebecca E. Zorn exercised 1,000 employee stock options on November 11, 2026, at $98.32 per share, acquiring 1,000 common shares. Concurrently, she sold 1,000 common shares at $161.5301 per share and gifted an additional 166 common shares. The insider transaction resulted in an approximate pre-tax spread of $63,000 from the exercise and sale.

Raymond James reiterates Strong Buy on Globe Life stock, $208 target

https://www.investing.com/news/analyst-ratings/raymond-james-reiterates-strong-buy-on-globe-life-stock-208-target-93CH-5021366
Raymond James has reiterated a Strong Buy rating on Globe Life (NYSE:GL) stock, setting a $208.00 price target, following meetings with company leadership. The firm highlighted Globe Life's expected increase in excess cash flows to $850-950 million in 2027 and its consistent capital return to shareholders through buybacks and dividends. While American Income Life shows positive signs of agent count stabilization and rising productivity, other analysts like Wells Fargo and Piper Sandler have expressed concerns about medical claims volatility, leading to lowered price targets.

An executive proposes selling 1,000 Globe Life (GL) shares acquired through an option exercise.

https://www.stocktitan.net/sec-filings/GL/144-globe-life-inc-sec-filing-ef7405aa7487.html
Globe Life Inc. executive officer Rebecca E. Zorn has filed a Form 144 notice proposing the sale of 1,000 common shares, valued at an aggregate market value of $159,790. These shares were acquired through a stock option exercise on November 11, 2026, which is also listed as the approximate sale date. The filing provides details on the acquisition and the proposed transaction.
Advertisement

Raymond James reiterates Strong Buy on Globe Life stock, $208 target

https://ca.investing.com/news/stock-market-news/raymond-james-reiterates-strong-buy-on-globe-life-stock-208-target-93CH-4952466
Raymond James has reiterated a "Strong Buy" rating for Globe Life (NYSE:GL) stock, maintaining a $208 price target after meetings with company leadership. The firm projects strong excess cash flows for Globe Life, expecting $850-950 million in 2027, an increase from 2026, and highlights the company's consistent dividend growth and share buybacks. Despite some positive operational signs like stabilized agent counts, other analysts have expressed concerns regarding medical claims volatility and lowered their price targets.

Behavioral Patterns of GL and Institutional Flows

https://news.stocktradersdaily.com/news_release/16/Behavioral_Patterns_of_GL_and_Institutional_Flows_111126013801_1794422281.html
This report analyzes the behavioral patterns of Globe Life Inc. (NYSE: GL) using AI models to generate trading strategies. It identifies positive near-term sentiment potentially eroding a mid-term weak bias within a long-term strength context, with elevated downside risk due to a lack of additional long-term support signals. The analysis provides specific long, breakout, and short strategies with entry, target, and stop levels based on multi-timeframe signal analysis.

Invesco Ltd. Reports 6.5% Stake in Globe Life Inc via Amended Schedule 13G Filing

https://kalkinemedia.com/us/news/announcements/invesco-ltd-reports-65-stake-in-globe-life-inc-via-amended-schedule-13g-filing
Invesco Ltd. has filed an amended Schedule 13G with the SEC, disclosing a 6.5% beneficial ownership stake in Globe Life Inc, totaling 5,020,088 shares of common stock as of September 30, 2026. The filing indicates that Invesco Ltd. acts as a parent holding company for its investment advisers, with shares held on behalf of clients. The firm holds sole voting and dispositive power over most of these shares, affirming the acquisition was for ordinary business purposes and not to influence control of Globe Life Inc.

Voting power over 5 million shares accompanies Invesco's amended Globe Life (GL) stake report.

https://www.stocktitan.net/sec-filings/GL/schedule-13g-a-globe-life-inc-amended-passive-investment-disclosure-a7ce9c57c640.html
Invesco Ltd. has filed an amended beneficial ownership report for Globe Life Inc. (GL), disclosing a 6.5% stake, representing 5,020,088 shares. While Invesco holds sole voting power over 5,005,015 shares and sole dispositive power over all 5,020,088 shares, the shares are held of record by its clients who retain rights to dividends and sale proceeds. The filing clarifies that no single client has more than 5% economic ownership.

W. R. Berkley Corporation (WRB) stock price, news, quote and history

https://sg.finance.yahoo.com/quote/WRB/
This article provides a detailed financial overview of W. R. Berkley Corporation (WRB), including its stock performance, key financial statistics, and company profile. It covers market data such as price, volume, market cap, and dividend information, alongside an overview of its insurance and reinsurance operations. The article also includes performance comparisons against the S&P 500, earnings trends, analyst ratings, and valuation measures.
Advertisement

Zacks Industry Outlook Highlights Aflac, Unum, Globe, Trupanion and Employers

https://finance.yahoo.com/healthcare/articles/zacks-industry-outlook-highlights-aflac-141300824.html
The Zacks Accident and Health Insurance industry is expected to grow due to increased underwriting exposure and demand for group insurance and supplemental health products. While companies like Aflac, Unum, Globe Life, Trupanion, and Employers Holdings are positioned to benefit, the industry faces challenges from persistent medical inflation and pricing pressures. Technology adoption is increasing efficiency, but higher investment costs may impact expense ratios.

Globe Life declares $0.33 dividend

https://www.tradingview.com/news/seekingalpha:2ea9ae960094b:0-globe-life-declares-0-33-dividend/
Globe Life (GL) has declared a quarterly dividend of $0.33 per share, maintaining its previous dividend payout. This dividend represents a forward yield of 0.83% and is payable on February 1st to shareholders of record as of January 8th, with an ex-dividend date also on January 8th.

Globe Life Inc. (GL) Declares $0.33 Quarterly Dividend; 0.8% Yield

https://www.streetinsider.com/Dividends/Globe+Life+Inc.+%28GL%29+Declares+%240.33+Quarterly+Dividend%3B+0.8%25+Yield/27301444.html
Globe Life Inc. (NYSE: GL) has declared a quarterly dividend of $0.33 per share, totaling $1.32 annualized, representing an annual yield of 0.8 percent. The dividend is payable on February 1, 2027, to shareholders of record as of January 8, 2027, with an ex-dividend date of January 7, 2027.

GLOBE LIFE INC. DECLARES DIVIDEND

https://www.streetinsider.com/PRNewswire/GLOBE+LIFE+INC.+DECLARES+DIVIDEND/27301391.html
Globe Life Inc. (NYSE: GL) has announced that its Board of Directors declared a quarterly dividend of $0.33 per share. This dividend will be paid on February 1, 2027, to shareholders of record as of January 8, 2027. Globe Life Inc. specializes in life and supplemental health insurance for the middle-income market.

Shareholders will get 33 cents per share from Globe Life on Feb. 1

https://www.stocktitan.net/news/GL/globe-life-inc-declares-4axsh0wv8umv.html
Globe Life (NYSE: GL) has declared a quarterly dividend of $0.33 per share on its common stock. This dividend will be paid on February 1, 2027, to shareholders of record as of the close of business on January 8, 2027. Globe Life Inc. is a holding company specializing in life and supplemental health insurance.
Advertisement

Globe Life Inc. (GL) Declares $0.33 Quarterly Dividend

https://www.tradingview.com/news/tradingview:4adc27917e5f5:0-globe-life-inc-gl-declares-0-33-quarterly-dividend/
Globe Life Inc. (GL) has declared a quarterly dividend of $0.33 per share. Shareholders of record by January 8, 2027, will be eligible to receive the payment on February 1, 2027. This is a routine dividend declaration and not an update on operating or financial performance.

5 Accident & Health Insurers to Watch Despite Cost Pressure

https://www.tradingview.com/news/zacks:443ba2d4f094b:0-5-accident-health-insurers-to-watch-despite-cost-pressure/
The Accident and Health Insurance industry is poised for growth despite challenges like pricing pressure and medical inflation, driven by increased underwriting exposure and rising demand for supplemental health products. This article highlights five key insurers—Aflac (AFL), Unum Group (UNM), Globe Life (GL), Trupanion (TRUP), and Employers Holdings (EIG)—that are well-positioned to capitalize on these trends through strategic investments, product innovation, and strong market presence. The industry is also benefiting from technological advancements like AI and data analytics, though initial investment costs remain a factor.

GLOBE LIFE INC. DECLARES DIVIDEND

https://www.prnewswire.com/news-releases/globe-life-inc-declares-dividend-302931392.html
Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of $0.33 per share. The dividend is for outstanding common stock held of record as of January 8, 2027, and will be paid on February 1, 2027. Globe Life Inc. specializes in life and supplemental health insurance for the middle-income market.

WHITE MOUNTAINS REPORTS THIRD QUARTER RESULTS

https://www.tradingview.com/news/prnewswire:0b4c2b05391aa:0-white-mountains-reports-third-quarter-results/
White Mountains Insurance Group, Ltd. (WTM) reported a 1% decrease in book value per share for the third quarter of 2026, totaling $2,243 as of September 30, 2026, primarily due to unrealized investment losses driven by higher interest rates and a lower share price at MediaAlpha. Despite these losses, the company's operating results were solid, with Ark achieving a 75% combined ratio and strong gross written premiums. White Mountains also announced its agreement to sell 5.5 million shares of MediaAlpha.

Kemper stock: Q3 profit outlook leaves auto recovery unfinished

https://www.ad-hoc-news.de/boerse/news/nebenwerte/kemper-stock-q3-profit-outlook-leaves-auto-recovery-unfinished/70460482
Kemper Corporation projects a return to profit for the third quarter of 2026, with net income expected to be around USD 52 million after a significant loss in the prior quarter. Despite this, the recovery in its Specialty Auto segment remains incomplete, as underlying underwriting still posted a loss, indicating ongoing profitability challenges in its core insurance operations. Investors are looking to the full Q3 results and the insurer's ability to achieve sustained improvement in its underlying combined ratio below 100%.
Advertisement

Mirae Asset Global Investments Co. Ltd. Acquires 177,338 Shares of Hershey Company (The) $HSY

https://www.marketbeat.com/instant-alerts/filing-mirae-asset-global-investments-co-ltd-acquires-177338-shares-of-hershey-company-the-hsy-2026-11-03/
Mirae Asset Global Investments Co. Ltd. recently acquired 177,338 shares of The Hershey Company (NYSE:HSY) during the third quarter, a new position valued at approximately $27.95 million. This acquisition makes Mirae Asset Global Investments Co. Ltd. the owner of about 0.09% of Hershey's stock. Other institutional investors also adjusted their holdings in Hershey, with the company's stock currently trading at $171.24 and holding a consensus "Hold" rating from analysts.

ProShare Advisors LLC Acquires 36,977 Shares of Old Republic International Corporation $ORI

https://www.marketbeat.com/instant-alerts/filing-proshare-advisors-llc-acquires-36977-shares-of-old-republic-international-corporation-ori-2026-11-03/
ProShare Advisors LLC increased its stake in Old Republic International Corporation by 5.9% in the third quarter of 2026, purchasing an additional 36,977 shares to bring its total holdings to 660,691 shares valued at approximately $24.65 million. The insurance provider's stock recently traded at $39.02, has a market capitalization of $9.42 billion, and offers a 3.2% dividend yield. Despite missing analyst consensus on quarterly EPS, the company's revenue exceeded estimates, and analysts maintain a "Moderate Buy" rating with an average price target of $43.50.

Globe Life (GL) - Teleconferência de Resultados do 3º Trimestre de 2026: Sinistros de Saúde Reduzem Projeção de LPA

https://www.tradingkey.com/pt/news/transcripts/262234220-TradingKey
Globe Life Inc. (NYSE: GL) relatou um modesto crescimento no lucro operacional do terceiro trimestre de 2026, impulsionado por prêmios mais altos, mas problemas no processamento do Medicare Supplement e sinistros graves na Evry pressionaram as margens de saúde, levando a uma redução na projeção de lucro por ação para o ano todo. A administração reduziu a projeção de LPA operacional líquido para 2026 para US$ 15,35-US$ 15,65, mas estimou um LPA de US$ 16,10-US$ 17,10 para 2027, com crescimento sustentado por recompras de ações e um fluxo de caixa excedente de US$ 850 milhões a US$ 950 milhões.

Updated Guidance Could Be A Game Changer For Globe Life (GL)

https://simplywall.st/stocks/us/insurance/nyse-gl/globe-life/news/updated-guidance-could-be-a-game-changer-for-globe-life-gl
Globe Life (GL) recently released its Q3 2026 results and provided detailed guidance for 2026 and 2027, projecting higher revenue and a shift in business mix with faster growth in health and Liberty National premiums compared to life premiums. This updated outlook offers investors clearer insight into the company's future growth drivers, especially emphasizing health lines as key volume drivers. The guidance supports the operating thesis of continued premium revenue growth and controlled expenses, with the main risk remaining margin pressure if health obligations or direct-to-consumer softness persist.

(GL) Volatility Zones as Tactical Triggers

https://news.stocktradersdaily.com/news_release/21/GL_Volatility_Zones_as_Tactical_Triggers_110126014002_1793558402.html
This article provides an AI-generated analysis of Globe Life Inc. (NYSE: GL), highlighting a positive near-term sentiment that may counter a mid-term weak bias within a strong long-term context. It outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, complete with entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal analysis for near-term, mid-term, and long-term horizons, indicating support and resistance levels.
Advertisement

Fund Update: 2,123,282 GLOBE LIFE (GL) shares added to PZENA INVESTMENT MANAGEMENT LLC portfolio

https://www.quiverquant.com/news/Fund+Update:+2,123,282+GLOBE+LIFE+(GL)+shares+added+to+PZENA+INVESTMENT+MANAGEMENT+LLC+portfolio
PZENA INVESTMENT MANAGEMENT LLC has significantly increased its stake in GLOBE LIFE (GL), adding over 2.1 million shares to its portfolio as of the Q3 2026 report period. This move highlights substantial institutional interest, with 303 investors adding GL shares while 311 decreased positions in the most recent quarter. Insider trading data for GL shows 45 sales and no purchases by company insiders over the past six months, with several executives selling large quantities of shares.

Fund Update: 2,123,282 GLOBE LIFE (GL) shares added to PZENA INVESTMENT MANAGEMENT LLC portfolio

https://www.quiverquant.com/news/Fund+Update%3A+2%2C123%2C282+GLOBE+LIFE+%28GL%29+shares+added+to+PZENA+INVESTMENT+MANAGEMENT+LLC+portfolio
PZENA INVESTMENT MANAGEMENT LLC has significantly increased its stake in GLOBE LIFE (GL) by adding over 2.1 million shares to its portfolio, as per a recent SEC 13F filing for the Q3 2026 report period. This move makes PZENA one of the largest institutional owners of GL, with the addition representing a 156.6% increase in their holdings. The article also details recent insider selling activity for GL stock and analyst price targets.

Globe Life Inc. (GL) Seasonal Returns Chart - Yahoo Finance

https://ca.finance.yahoo.com/quote/GL/seasonality/
The article presents a seasonal returns chart for Globe Life Inc. (GL), displaying the average monthly price return for the period between 2016 and 2026. It also provides current stock information, including the closing price and after-hours trading data. The page seems to have encountered an error during loading.

CNO Financial Group Reports Third Quarter 2026 Results

https://www.tradingview.com/news/prnewswire:b4630d7f0a87a:0-cno-financial-group-reports-third-quarter-2026-results/
CNO Financial Group announced strong third-quarter 2026 financial results, raising its full-year operating earnings per share guidance by 9%. The company reported a 47% increase in operating EPS for the quarter and continued its sales growth for the 17th consecutive quarter. CNO also completed its third reinsurance transaction with its Bermuda affiliate, further supporting its strategic focus.

Globe Life Inc. stock underperforms Thursday when compared to competitors despite daily gains

https://www.marketwatch.com/data-news/globe-life-inc-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-3f1e3470-313caa36d7b0?mod=goog_fin_scmw
Globe Life Inc. (GL) stock rose 1.31% on Thursday, closing at $160.45. Despite this gain, the stock underperformed compared to the broader market, as the S&P 500 Index fell 0.30% and the Dow Jones Industrial Average fell 0.25%. This marks the fourth consecutive day of gains for Globe Life Inc. shares.
Advertisement

Hippo Holdings Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/10/62693165/hippo-holdings-q3-2026-earnings-call-transcript
Hippo Holdings reported its fifth consecutive quarter of underwriting profitability in Q3 2026, with a net income of $9 million and adjusted net income of $20 million. Gross written premiums increased by 60% year-over-year to nearly $500 million, driven by growth in casualty and commercial multi-peril lines, while the combined ratio improved to 98.4%. The company also raised its full-year guidance for gross written premium and adjusted net income, emphasizing its strategy of diversification, underwriting discipline, and leveraging AI for efficiency.

Globe Life Executive VP & Chief Strategy Officer Michael Majors Sells 27% Of Holding

https://simplywall.st/stocks/us/insurance/nyse-gl/globe-life/news/globe-life-executive-vp-chief-strategy-officer-michael-major
Michael Majors, Executive VP & Chief Strategy Officer at Globe Life Inc. (NYSE:GL), recently sold shares worth US$2.2m, decreasing his holding by 27%. This was the largest insider sale in the past year, prompting caution despite the company's profitability and strong insider ownership. The article highlights that no insiders have bought shares in the last year, suggesting a need for investors to consider the implications of this selling activity.

Globe Life evp & cio Hensley sells $372,620 of stock

https://www.investing.com/news/insider-trading-news/globe-life-evp--cio-hensley-sells-372620-of-stock-93CH-4976679
Robert Edward Hensley, EVP and CIO at Globe Life Inc., sold 2,569 shares of company stock worth $372,620 on March 2, 2026. This sale occurred as Globe Life's shares declined 7.6% over the previous week, though the stock remains undervalued according to InvestingPro analysis, with the company consistently raising its dividend. Recent financial reports showed Globe Life's Q3 2026 net operating income missed estimates, while revenue exceeded expectations, with analysts adjusting price targets due to concerns over the health segment.

Form 4 Globe Life Inc: Robert Edward Hensley (EVP & Chief Investment Officer) For: 2 March By Investing.com

https://ng.investing.com/news/stock-market-news/form-4-globe-life-inc-robert-edward-hensley-evp--chief-investment-officer-for-2-march-93CH-2761089
This article reports on a Form 4 filing from Globe Life Inc., detailing transactions made by Robert Edward Hensley, the EVP & Chief Investment Officer, on March 2. Form 4 filings provide public notification of insider transactions, offering transparency into how company executives are trading their own stock. The brief announcement provides the company name, the insider's name and title, and the date of the reported activity.

Form 4 Globe Life Inc: Robert Edward Hensley (EVP & Chief Investment Officer) For: 2 March By Investing.com

https://uk.investing.com/news/stock-market-news/form-4-globe-life-inc-robert-edward-hensley-evp--chief-investment-officer-for-2-march-93CH-4935302
This article reports a Form 4 filing for Globe Life Inc., detailing transactions made by Robert Edward Hensley, EVP & Chief Investment Officer, on March 2nd. The filing provides insight into insider activity for the company, specifically concerning Mr. Hensley's holdings. The publication date of the article is October 27, 2026, though the transaction date is March 2.
Advertisement

Globe Life evp & cio Hensley sells $372,620 of stock By Investing.com

https://uk.investing.com/news/stock-market-news/globe-life-evp--cio-hensley-sells-372620-of-stock-93CH-4935299
Robert Edward Hensley, EVP and CIO at Globe Life Inc., sold 2,569 shares of company stock totaling $372,620 on March 2, 2026, at prices between $144.76 and $145.33 per share. This transaction occurred amidst a 7.6% decline in Globe Life shares over the past week, though the stock currently trades above the sale price. Despite the sale, InvestingPro analysis suggests the stock is undervalued with "GOOD" financial health, and the company has consistently raised its dividend for 11 years.

Law firm probes Globe Life officers for possible breach of duties to shareholders

https://pluang.com/en/news-feed/globe-life-inc-pelanggaran-tugas-fidusia-pemegang-saham
Halper Sadeh LLC is investigating whether certain officers and directors of Globe Life Inc. (GL) breached their fiduciary duties to shareholders, potentially allowing long-term shareholders to seek reforms or financial relief. The firm offers free consultations and works on a contingent fee basis, urging prompt action due to time limits. This investigation aims to enhance corporate governance and safeguard shareholder interests.

Everest Group (EG) Nears Earnings As A Slight Undervalued View Holds

https://simplywall.st/stocks/us/insurance/nyse-eg/everest-group/news/everest-group-eg-nears-earnings-as-a-slight-undervalued-view
Everest Group (EG) is approaching its next earnings release with a slight undervaluation according to Simply Wall St's analysis. Despite previously missing revenue expectations and facing forecasts of continued top-line pressure, the stock has seen a 7.34% increase in the last month. The company's fair value is estimated at $408.47 against a current price of $397.61, driven by its operating ROE, capital return, and growing use of third-party capital.

How Investors Are Reacting To Globe Life (GL) Updated Growth Guidance

https://simplywall.st/stocks/us/insurance/nyse-gl/globe-life/news/how-investors-are-reacting-to-globe-life-gl-updated-growth-g
Globe Life (GL) has released updated growth guidance for 2026 and 2027, detailing expected premium trends, EPS ranges, and sales growth targets across its life and health insurance segments. The guidance projects 6% to 8% total premium growth and 7% midpoint EPS growth, reinforcing the company's "slow and steady" investment narrative. Investors are now focused on consistent execution against these targets to rebuild confidence after previous misses.

Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)

https://www.morningstar.com/news/pr-newswire/20261026ny81489/globe-life-inc-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-globe-life-inc-gl
SueWallSt has initiated an investigation into Globe Life Inc. (GL) following a disclosure of approximately $7 million in excess prior-period Medicare Supplement claims, which caused GL shares to drop over 8%. The investigation focuses on whether the company adequately informed investors about its exposure to CMS claims processing changes. Shareholders who incurred losses are encouraged to contact SueWallSt for a free review of their investment.
Advertisement

Globe Life evp Michael Majors sells $2.22M in common stock

https://www.investing.com/news/insider-trading-news/globe-life-evp-michael-majors-sells-222m-in-common-stock-93CH-4973736
Michael Clay Majors, EVP and Chief Strategy Officer at Globe Life Inc., sold 14,377 shares of common stock for approximately $2.22 million on October 23, 2026. This transaction occurred amidst recent financial results where Globe Life reported a Q3 2026 net operating income miss, though revenue exceeded forecasts. Analyst firms Wells Fargo and Piper Sandler have adjusted their price targets and ratings due to concerns over health segment performance and medical claims volatility.

Globe Life shares drop 8% after $7M Medicare claims delay revealed

https://pluang.com/en/news-feed/pemberitahuan-investigasi-globe-life-inc
Globe Life's shares dropped over 8% after the company disclosed $7 million in excess Medicare Supplement claims from previous periods, attributed to a CMS processing delay affecting its United American division. An investigation is underway regarding the adequacy of Globe Life's disclosures concerning its exposure to CMS claims processing issues. Investors who incurred losses may be eligible to participate in legal action.

Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)

https://www.prnewswire.com/news-releases/globe-life-inc-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-globe-life-inc-gl-302919923.html
SueWallSt has announced an investigation into Globe Life Inc. (GL) following an over 8% drop in its share price. This decline occurred after the company disclosed approximately $7 million in excess prior-period Medicare Supplement claims due to a CMS processing delay. The investigation aims to determine if Globe Life Inc. adequately disclosed its exposure to CMS claims-processing changes to investors.

Globe Life evp Michael Majors sells $2.22M in common stock

https://ca.investing.com/news/stock-market-news/globe-life-evp-michael-majors-sells-222m-in-common-stock-93CH-4904041
Michael Clay Majors, Executive Vice President and Chief Strategy Officer at Globe Life Inc., sold 14,377 shares of company stock for approximately $2.22 million on October 23, 2026. This transaction follows the company's Q3 2026 financial results, where net operating income missed estimates but revenue surpassed forecasts. Analyst firms Wells Fargo and Piper Sandler recently adjusted their price targets and ratings for Globe Life due to concerns about volatility in medical claims and uneven health segment performance.

After selling 14,377 shares, Globe Life (GL) executive holds 39,141 directly.

https://www.stocktitan.net/sec-filings/GL/form-4-globe-life-inc-insider-trading-activity-4eba0543afed.html
Michael Clay Majors, EVP - Chief Strategy Officer of Globe Life Inc. (GL), sold 14,377 shares of common stock on October 23, 2026, for approximately $2.22 million, with prices ranging from $154.125 to $154.77 per share. Following this transaction, he directly holds 39,141 shares. No Rule 10b5-1 plan was reported for this sale.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement